BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Department of Medicine - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/medicine
X-WR-CALDESC:Events for Department of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180405T120000
DTEND;TZID=America/New_York:20180405T130000
DTSTAMP:20260618T115350
CREATED:20180405T160000Z
LAST-MODIFIED:20190307T184800Z
UID:10000993-1522929600-1522933200@www.med.unc.edu
SUMMARY:Medicine Grand Rounds\, Nigel Key "Hemophilia\, A 100-Year Story"
DESCRIPTION:Although it’s been nearly a century since hemophilia was considered an early death sentence\, treating it can be time-consuming and troublesome. Many people with the blood disease give themselves frequent drug infusions to keep their condition under control\, sometimes as often as several times a week. \nSeveral newly approved medications\, while far from a cure\, aim to lift some of that burden. Some will allow patients to go longer between treatments. Another drug in development aims to overcome a problem with current treatments\, which can sometimes stop working for people whose bodies become resistant to them. \n“There’s never been a time when the pipeline is as full as it is now\,” says Nigel Key\, MB\, ChB\, a hematologist and director of the UNC Hemophilia and Thrombosis Center. “I think it’s a reflection of the ability of biotechnology to bring these things forward.” \nDr. Key is Vice Chief of the Division of Hematology/Oncology. His practice is limited to patients with non-malignant blood disorders. His particular interests are in bleeding and clotting disorders.
URL:https://www.med.unc.edu/medicine/event/apr-5/
CATEGORIES:Medicine Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/nigel-key.jpeg
END:VEVENT
END:VCALENDAR